Life Sciences Times

FDA Approves SetPoint Medical’s Neuroimmune Modulation Device for Rheumatoid Arthritis

Merz Aesthetics Expands U.S. Leadership Team with Key Sales and Marketing Appointments

Cardiosense Wins FDA Clearance for CardioTag, a Wearable Device for Noninvasive Cardiac Monitoring

Promega Commits to Science-Based Climate Targets to Reduce Global Emissions

Purilogics Introduces First Manufacturing-Grade Membrane Chromatography Product for GMP Use

VideaHealth Unveils ClaimsAI to Cut Dental Industry’s $15 Billion Revenue Cycle Waste

Be Biopharma Doses First Participant in Clinical Trial for Engineered B Cell Therapy in Hemophilia B

Flynn Life Sciences Names Chris DeMaina CEO Amid Strategic Rebrand

Massachusetts Jury Awards Record $42.6 Million in Johnson & Johnson Asbestos Baby Powder Case

Viridian Therapeutics Signs $385 Million Deal with Kissei to Develop Thyroid Eye Disease Treatments in Japan